HopeStage
Back to all studies
RecruitingNCT07506395

Group psilocybin-assisted therapy for post-traumatic stress

About this titleRead the official source — NCT07506395
Medication studyAges 18–89United StatesPTSD
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 89 years.

Listed locations
AlbuquerqueSee all locations and recruitment
Study phase
Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: May 1, 2026
Recruitment status
Recruiting
Enrollment listed in the registry
36
Sponsor
University of New Mexico
Sponsor type
University
Study type
Drug
Intervention type
Medication / drug
Study phase
Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
Locations
United States
Age range
From 18 Years to 89 Years
Official registry ID
NCT07506395
Official title
Show the full official title

Group Psilocybin-Assisted Therapy for Post-Traumatic Stress Disorder

Recruitment & locations

Currently recruiting

Albuquerque

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is University of New Mexico, a university.

Does this study involve medication?

Yes. The study involves medication, including Psilocybin.

Who can participate?

Listed age limits: 18 years to 89 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies